Agents and Actions

, Volume 7, Issue 5–6, pp 533–538 | Cite as

Effect of calcitonin on different inflammatory models

  • S. E. Abdullahi
  • E. Arrigoni Martelli
  • E. Bramm
  • L. Franco
  • G. P. Velo
Immunosuppression and Inflammation


The effect of synthetic salmon calcitonin was studied on adjuvant arthritis, pertussis vaccine edema, tuberculin skin reaction, passive direct Arthus reaction and nystatin edema. The results show that calcitonin inhibits these inflammatory processes.


Arthritis Inflammatory Process Calcitonin Pertussis Skin Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    G. Milhaud andM.S. Moukhtar,Thyrocalcitonin: Effects on Calcium Kinetics in the Rat, Proc. Soc. Exp. Biol. Med.123, 207 (1966).PubMedGoogle Scholar
  2. [2]
    P.F. Hirsh, A. Shiwoski, H. Orimo, L. Dorago, R. Mewborn,On the Mode of the Hypocalcemie Action of Thyrocalcitonin and its Enhancement by Phosphate in Rats, Endocrinology93, 12 (1973).PubMedGoogle Scholar
  3. [3]
    J. Friedman andL.G. Raisz,Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue Culture, Science150, 1465 (1965).PubMedGoogle Scholar
  4. [4]
    D.N. Kalu andG.V. Foster,Effect of Calcitonin on 3 H Proline Incorporation into Bone Hydroxyproline in the Rat, J. Endocrinol.49, 233 (1971).PubMedGoogle Scholar
  5. [5]
    A.W. Wase, J. Solewki, E. Riches andJ. Seidenberg,Action of Thyrocalcitonin on Bone, Nature214, 388 (1967).PubMedGoogle Scholar
  6. [6]
    O.L.M. Bijovet, J. Van der Sluys Veer andA.P. Jansen,Effects of Calcitonin on Patients with Paget's Disease, Thyrotoxicosis, or Hypercalcaemia, Lancet1, 876 (1968).PubMedGoogle Scholar
  7. [7]
    S. Wallach, J. Aloga andS. Cohn,Treatment of Osteoporosis with Calcitonin, Semin. Drug Treat.2, 21 (1972).PubMedGoogle Scholar
  8. [8]
    L. Riesterer andR. Jaques,Reduction of Increased Vascular Permeability by Calcitonin, Pharmacology3, 53 (1969).Google Scholar
  9. [9]
    S.E. Abdullahi, G. De Bastiani, L. Nogarin andG.P. Velo,Effect of Calcitonin on Carrageenan Foot Oedema, Agents and Actions5 (4), 371 (1975).PubMedGoogle Scholar
  10. [10]
    G.P. Velo, G. De Bastiani, L. Nogarin andS.E. Abdullahi,Anti-Inflammatory Effect of Calcitonin, in:Future Trends in Inflammation II (Eds. J.P. Giroud, D.A. Willoughby and G.P. Velo; Birkhäuser Verlag, Basel and Stuttgart, 1975), p. 284.Google Scholar
  11. [11]
    G.R. Bobalik, J.P. Aldred, R.R. Kleszynski, R.U. Stubbs, R.A. Zeedyk andJ.W. Bastian,Effects of Salmon Calcitonin and Combination Drug Therapy on Rat Adjuvant Arthritis, Agents and Actions4 (5), 364 (1974).PubMedGoogle Scholar
  12. [12]
    E. Arrigoni-Martelli, E. Bramm, E.C. Huskisson, D.A. Willoughby andP.A. Dieppe,Pertussis Vaccine Oedema: An Experimental Model for the Action of Penicillamine-Like Drugs. Agents and Actions6 (5), 613 (1976).PubMedGoogle Scholar
  13. [13]
    H. Megel, A. Raychandhuri, I. Shermano, T.H. Beaver andL.L. Thomas,The Anti-Inflammatory Actions of Tirolone Hydrochloride, Proc. Soc. Exp. Biol. Med.149, 89 (1975).PubMedGoogle Scholar
  14. [14]
    E. Arrigoni-Martelli, P. Schiatti andD. Selva,The Influence of Anti-Inflammatory and Immunosuppressant Drugs on Nystatin Induced Oedema, Pharmacology5, 215 (1971).PubMedGoogle Scholar
  15. [15]
    C.G. Cochrane andF.J. Dixon, in:Textbook of Immunopathology, vol. 1 (Eds. P.A. Miescher and H.J. Müller-Eberhard; Grune-Stratton, New York, 1968), p. 94.Google Scholar
  16. [16]
    J.P. Aldred, R.R. Kleszynski andJ.W. Bastian,Effects of Acute Administration of Porcine and Salmon Calcitonin on Urine Electrolyte Excretion in Rats, Proc. Soc. Exp. Biol. Med.134, 1175 (1970).PubMedGoogle Scholar
  17. [17]
    W. Braun andM. Ishizuka,Suppression and Enhancement of Antibody Formation by Alteration of Ca 2+ Levels, Nature226, 945 (1970).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1977

Authors and Affiliations

  • S. E. Abdullahi
    • 1
  • E. Arrigoni Martelli
    • 2
  • E. Bramm
    • 2
  • L. Franco
    • 1
  • G. P. Velo
    • 1
  1. 1.Istituto di FarmacologiaPoliclinico Borgo RomaVeronaItaly
  2. 2.Department of PharmacologyLeo Pharmaceutical ProductsBallerupDenmark

Personalised recommendations